Bladder tissue uptake of mitomycin C during intravesical therapy is linear with drug concentration in urine

Clinical Cancer Research

Volumn 4, Issue 1, 1998, Pages 139-143

  Gao, Xiang ^a   Au, Jessie L S ^a,b   Badalament, Robert A ^b   Wientjes, M Guillaume ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTECTOMY; DOG; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG INSTILLATION; DRUG PENETRATION; DRUG UPTAKE; DRUG URINE LEVEL; FEMALE; HUMAN; HUMAN TISSUE; INTRAVESICAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, INTRAVESICAL; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MITOMYCIN; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 0031883090     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Richie, J. P. Intravesical chemotherapy. Urol. Clin. North Am., 19: 521-527, 1992.
2. Perry, J. J., and Muss, H. B. Management of disseminated disease in the patient with bladder cancer. Urol. Clin. North Am., 21: 661-672, 1994.
3. Dalton, J. T., Wientjes, M. G., Badalament, R. A., Drago, J. R., and Au, J. L-S. Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer patients. Cancer Res., 57: 5144-5152, 1991.
4. Schmittgen, T. D., Au, J. L-S., Wientjes, M. G., and Badalament, R. A. Pharmacodynamics of mitomycin C in cultured human bladder tumors. Cancer Res., 57: 3849-3856, 1991.
5. Wientjes, M. G., Dalton, J. T., Badalament, R. A., Drago, J. R., and Au, J. L-S. Bladder wall penetration of intravesical mitomycin C in dogs. Cancer Res., 51: 4347-4354, 1991.
6. Wientjes, M. G., Badalament, R. A., and Au, J. L-S. Use of pharmacologic data and computer simulations to design an efficacy trial of intravesical mitomycin C therapy for superficial bladder cancer. Cancer Chemother. Pharmacol., 32: 255-262, 1993.
7. Au, J. L-S. Integrated pharmacokinetic and pharmacodynamic studies to improve intravesical treatment of bladder cancer. Cancer Bull., 46: 48-57, 1994.
8. Wientjes, M. G., Dalton, J. T., Badalament, R. A., Dasani, B. M., Drago, J. R., and Au, J. L-S. A method to study drug concentration-depth profiles in tissues: mitomycin C in dog bladder wall. Pharm. Res. (NY), 8: 168-173, 1991.
9. Dalton, J. T., Geuns, G. R., and Au, J. L-S. High performance liquid chromatographic determination of mitomycin C in rat and human plasma and urine. J. Chromatogr., 495: 330-337, 1989.
10. Eksborg, S., Ehrsson, H., and Lindfors, A. Liquid chromatographic determination of mitomycin C in human plasma and urine. J. Chromatogr., 274: 263-270, 1983.
11. Dedrick, R., Flessner, M. F., Collins, J. M., and Schultz, J. S. Is the peritoneum a membrane? Am. Soc. Artific. Int. Org. J., 5: 1-8, 1982.
12. Herr, H. W. Intravesical therapy: a critical review. Urol. Clin. North Am., 14: 399-404, 1987.
13. Wientjes, M. G., Badalament, R. A., Wang, R. C., Hassan, F., and Au, J. L-S. Penetration of mitomycin C in human bladder. Cancer Res., 53: 3314-3320, 1993.
14. Kalns, J. E., Wientjes, M. G., Badalament, R. A., Cai, J. Z., and Au, J. L-S. Pharmacokinetic interventions to improve intravesical therapy of superficial bladder cancer. Proc. Am. Assoc. Cancer Res., 37: 171, 1996.
15. Crooke, S. T., Henderson, M., Samson, M., and Baker, L. H. Phase I study of oral mitomycin C. Cancer Treat. Rep., 60: 1633-1636, 1976.